Tom Stafford is professor of cognitive science at the University of Sheffield. His work applies insights from neuroscience, experimental design and data science to the topics decision-making, reasoning and bias. He is also senior research fellow at the Research on Research Institute, where he works with research funders to develop experiments that test improvements in the research funding system. Learn more.
Tom Stafford
Professor of cognitive science
University of Sheffield
From this contributor
Selected articles
- “Quantifying the benefits of using decision models with response time and accuracy data” | Behavior Research Methods
- “The experimental research funder’s handbook” | Research on Research Institute
- “The ideological Turing test: A behavioral measure of open-mindedness and perspective-taking” | Cognitive Science
Explore more from The Transmitter
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
To understand decision-making, we need to truly challenge lab animals
Complex, multidimensional tasks that unfold over time could reveal how different brain areas work together to support decisions.
By
Chand Chandrasekaran
20 April 2026 | 6 min read
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
‘Overdue’ debate unfurls over neuroimaging method
After a January paper questioned the validity of an approach called lesion network mapping, its users are pressure testing their results.
By
Angie Voyles Askham
17 April 2026 | 8 min read
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
Nearly 400 compounds affect behaviors tied to autism-linked genes in zebrafish
Estropipate, paclitaxel and levocarnitine altered behaviors tied to SCN2A and DYRK1A variants specifically, a new open-source platform revealed.
By
Charles Q. Choi
16 April 2026 | 4 min read